224 related articles for article (PubMed ID: 26233335)
1. Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine in healthy subjects.
Yoo H; Iirola T; Vilo S; Manner T; Aantaa R; Lahtinen M; Scheinin M; Olkkola KT; Jusko WJ
Eur J Clin Pharmacol; 2015 Oct; 71(10):1197-207. PubMed ID: 26233335
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of dexmedetomidine after intranasal administration.
Iirola T; Vilo S; Manner T; Aantaa R; Lahtinen M; Scheinin M; Olkkola KT
Eur J Clin Pharmacol; 2011 Aug; 67(8):825-31. PubMed ID: 21318594
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine.
Li A; Yuen VM; Goulay-Dufaÿ S; Sheng Y; Standing JF; Kwok PCL; Leung MKM; Leung AS; Wong ICK; Irwin MG
Br J Anaesth; 2018 May; 120(5):960-968. PubMed ID: 29661413
[TBL] [Abstract][Full Text] [Related]
5. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study.
Miller JW; Balyan R; Dong M; Mahmoud M; Lam JE; Pratap JN; Paquin JR; Li BL; Spaeth JP; Vinks A; Loepke AW
Br J Anaesth; 2018 May; 120(5):1056-1065. PubMed ID: 29661383
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneously administered dexmedetomidine is efficiently absorbed and is associated with attenuated cardiovascular effects in healthy volunteers.
Uusalo P; Al-Ramahi D; Tilli I; Aantaa RA; Scheinin M; Saari TI
Eur J Clin Pharmacol; 2018 Aug; 74(8):1047-1054. PubMed ID: 29666901
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamic effects of oral transmucosal and intravenous administration of dexmedetomidine in dogs.
Dent BT; Aarnes TK; Wavreille VA; Lakritz J; Lerche P; KuKanich B; Riccó Pereira CH; Bednarski RM
Am J Vet Res; 2019 Oct; 80(10):969-975. PubMed ID: 31556717
[TBL] [Abstract][Full Text] [Related]
9. Intranasal dexmedetomidine in healthy beagles: An echocardiographic and pharmacokinetic/pharmacodynamic study.
Santangelo B; Harel M; Fourel I; Micieli F; Cataldi M; Segard-Weisse E; Portier K
Vet J; 2019 Sep; 251():105346. PubMed ID: 31492384
[TBL] [Abstract][Full Text] [Related]
10. Population analysis to assess the influence of age and body weight on pharmacokinetics and pharmacodynamics of dexmedetomidine in New Zealand White rabbits.
Warzybok J; Bienert A; Borsuk-De Moor A; Płotek W; Kulińska K; Czerniak K; Billert H; Klupczyńska A; Matysiak J; Grześkowiak E; Wiczling P
Biopharm Drug Dispos; 2020 Jul; 41(7):307-316. PubMed ID: 32598039
[TBL] [Abstract][Full Text] [Related]
11. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine.
Bhana N; Goa KL; McClellan KJ
Drugs; 2000 Feb; 59(2):263-8; discussion 269-70. PubMed ID: 10730549
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic study of dexmedetomidine in elderly patients during spinal anesthesia.
Kuang Y; Zhang RR; Pei Q; Tan HY; Guo CX; Huang J; Xiang YX; Ouyang W; Duan KM; Wang SY; Yang GP
Int J Clin Pharmacol Ther; 2015 Dec; 53(12):1005-14. PubMed ID: 26413731
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Dexmedetomidine in Infants and Children After Orthotopic Liver Transplantation.
Damian MA; Hammer GB; Elkomy MH; Frymoyer A; Drover DR; Su F
Anesth Analg; 2020 Jan; 130(1):209-216. PubMed ID: 30198929
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients.
Iirola T; Ihmsen H; Laitio R; Kentala E; Aantaa R; Kurvinen JP; Scheinin M; Schwilden H; Schüttler J; Olkkola KT
Br J Anaesth; 2012 Mar; 108(3):460-8. PubMed ID: 22277665
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and Sedative Effects of Intranasal Dexmedetomidine in Ambulatory Pediatric Patients.
Uusalo P; Guillaume S; Siren S; Manner T; Vilo S; Scheinin M; Saari TI
Anesth Analg; 2020 Apr; 130(4):949-957. PubMed ID: 31206433
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine.
Yuen VM; Irwin MG; Hui TW; Yuen MK; Lee LH
Anesth Analg; 2007 Aug; 105(2):374-80. PubMed ID: 17646493
[TBL] [Abstract][Full Text] [Related]
18. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.
Scheinin H; Aantaa R; Anttila M; Hakola P; Helminen A; Karhuvaara S
Anesthesiology; 1998 Sep; 89(3):574-84. PubMed ID: 9743392
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients.
Ber J; Wiczling P; Hołysz M; Klupczyńska A; Bartkowska-Śniatkowska A; Bieda K; Smuszkiewicz P; Nowicka M; Żurański Ł; Sobczyński P; Matysiak J; Grześkowiak E; Bienert A
J Clin Pharmacol; 2020 Nov; 60(11):1461-1473. PubMed ID: 32500578
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine.
Scheinin H; Karhuvaara S; Olkkola KT; Kallio A; Anttila M; Vuorilehto L; Scheinin M
Clin Pharmacol Ther; 1992 Nov; 52(5):537-46. PubMed ID: 1358496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
